Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Ebeling

Showing results (31-40 of 379) with videos related to

Pageof 38
Sort By:
Therapeutic Advances in Musculoskeletal Disease|October 9, 2013
Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidenceIe-Wen Sim, Peter R Ebeling
Nutrients|January 19, 2012
Is excess calcium harmful to health?Robin M Daly, Peter R Ebeling
Nephrology (Carlton, Vic.)|April 22, 2017
Management of mineral and bone disorders in renal transplant recipientsMatthew J Damasiewicz, Peter R Ebeling
Osteoporosis and Sarcopenia|June 29, 2026
Atypical femur fractures: insights from the Asian Federation of Osteoporosis Societies consensus paperHanh H Nguyen, Peter R Ebeling
Clinical Biomechanics (Bristol, Avon)|August 27, 2014
Femoral shaft strains during daily activities: Implications for atypical femoral fracturesSaulo Martelli, Peter Pivonka, Peter R Ebeling
Internal Medicine Journal|January 10, 2018
Does obesity reduce risk for osteoporosis and fractures in older adults?David Scott, Gustavo Duque, Peter R Ebeling
Clinical Interventions in Aging|March 14, 2009
Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatmentClaudia Gagnon, Vivien Li, Peter R Ebeling
Bone|December 21, 2022
Cardiac adverse events in bisphosphonate and teriparatide users: An international pharmacovigilance studyAlexander J Rodríguez, Nitesh Nerlekar, Peter R Ebeling
The Journal of Clinical Endocrinology and Metabolism|August 23, 2013
Vitamin D, muscle function, and falls in older adults: does reduced deposition of intramuscular adipose tissue influence the relationship?David Scott, Kerrie M Sanders, Peter R Ebeling
Bone Reports|April 6, 2017
A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelateHanh H Nguyen, Frances Milat, Peter R Ebeling
Pageof 38

Showing results (31-40 of 379) with videos related to

Sort By:
Pageof 38
Therapeutic Advances in Musculoskeletal Disease|October 9, 2013
Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidenceIe-Wen Sim, Peter R Ebeling
Nutrients|January 19, 2012
Is excess calcium harmful to health?Robin M Daly, Peter R Ebeling
Nephrology (Carlton, Vic.)|April 22, 2017
Management of mineral and bone disorders in renal transplant recipientsMatthew J Damasiewicz, Peter R Ebeling
Osteoporosis and Sarcopenia|June 29, 2026
Atypical femur fractures: insights from the Asian Federation of Osteoporosis Societies consensus paperHanh H Nguyen, Peter R Ebeling
Clinical Biomechanics (Bristol, Avon)|August 27, 2014
Femoral shaft strains during daily activities: Implications for atypical femoral fracturesSaulo Martelli, Peter Pivonka, Peter R Ebeling
Internal Medicine Journal|January 10, 2018
Does obesity reduce risk for osteoporosis and fractures in older adults?David Scott, Gustavo Duque, Peter R Ebeling
Clinical Interventions in Aging|March 14, 2009
Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatmentClaudia Gagnon, Vivien Li, Peter R Ebeling
Bone|December 21, 2022
Cardiac adverse events in bisphosphonate and teriparatide users: An international pharmacovigilance studyAlexander J Rodríguez, Nitesh Nerlekar, Peter R Ebeling
The Journal of Clinical Endocrinology and Metabolism|August 23, 2013
Vitamin D, muscle function, and falls in older adults: does reduced deposition of intramuscular adipose tissue influence the relationship?David Scott, Kerrie M Sanders, Peter R Ebeling
Bone Reports|April 6, 2017
A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelateHanh H Nguyen, Frances Milat, Peter R Ebeling
Pageof 38